Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-006429
Filing Date
2025-06-18
Accepted
2025-06-18 15:36:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 29167
2 filename2.txt TEXT-EXTRACT 2635
  Complete submission text file 0000000000-25-006429.txt   43531
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filed for) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-288025
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)